- Home
- SBCF vs JANX Comparison
SBCF vs JANX Comparison
Compare SBCF & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- JANX
- Stock Information
- Founded
- SBCF 1926
- JANX 2017
- Country
- SBCF United States
- JANX United States
- Employees
- SBCF N/A
- JANX N/A
- Industry
- SBCF Major Banks
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- SBCF Finance
- JANX Health Care
- Exchange
- SBCF Nasdaq
- JANX Nasdaq
- Market Cap
- SBCF 2.5B
- JANX 2.9B
- IPO Year
- SBCF N/A
- JANX 2021
- Fundamental
- Price
- SBCF $29.50
- JANX $48.52
- Analyst Decision
- SBCF Hold
- JANX Strong Buy
- Analyst Count
- SBCF 5
- JANX 10
- Target Price
- SBCF $28.10
- JANX $65.10
- AVG Volume (30 Days)
- SBCF 433.8K
- JANX 675.5K
- Earning Date
- SBCF 10-24-2024
- JANX 11-06-2024
- Dividend Yield
- SBCF 2.44%
- JANX N/A
- EPS Growth
- SBCF 10.93
- JANX N/A
- EPS
- SBCF 1.36
- JANX N/A
- Revenue
- SBCF $494,135,000.00
- JANX $13,049,000.00
- Revenue This Year
- SBCF N/A
- JANX $66.30
- Revenue Next Year
- SBCF $8.42
- JANX N/A
- P/E Ratio
- SBCF $21.70
- JANX N/A
- Revenue Growth
- SBCF N/A
- JANX 54.12
- 52 Week Low
- SBCF $21.23
- JANX $7.79
- 52 Week High
- SBCF $30.78
- JANX $65.60
- Technical
- Relative Strength Index (RSI)
- SBCF 60.06
- JANX 39.32
- Support Level
- SBCF $29.09
- JANX $50.51
- Resistance Level
- SBCF $30.71
- JANX $57.48
- Average True Range (ATR)
- SBCF 0.85
- JANX 2.86
- MACD
- SBCF 0.18
- JANX -0.81
- Stochastic Oscillator
- SBCF 72.05
- JANX 0.66
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.